Johnson & Johnson Recalls Duragesic Pain Patches

Johnson & Johnson has recalled more than 53,000 Duragesic pain relief skin patches, according to a Wall Street Journal report.

Advertisement

The company said that at least one patch was found to have small crystals of the potent active ingredient.

Related Articles on Pain Management:

Convergence Pharmaceuticals Neuropatic Pain Drug Completes Phase I Trials
Trial for Boston Scientific’s Spinal Cord Stimulation Device Shows Promising Results
Oregon House Co-Speaker Visits Middle Fork Surgery Center for Pain Management Policy Discussion

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.